Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections

Applied Microbiology and Biotechnology

Volumn 100, Issue 14, 2016, Pages 6141-6148

  Nguyen, Angela T ^a   Oglesby Sherrouse, Amanda G ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Alkyl quinolones; Cystic fibrosis; Polymicrobial infections; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

PATHOGENS;

CYSTIC FIBROSIS; POLYMICROBIAL INFECTIONS; PSEUDOMONAS AERUGINOSA; QUINOLONES; STAPHYLOCOCCUS AUREUS;

BACTERIA;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

IRON;

BLOOD; COCULTURE; CYSTIC FIBROSIS; DISEASE COURSE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNITY; IMMUNOLOGY; MICROBIOLOGY; MIXED INFECTION; ORGANISMAL INTERACTION; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

COCULTURE TECHNIQUES; COINFECTION; CYSTIC FIBROSIS; DISEASE PROGRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; IRON; MICROBIAL INTERACTIONS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84971009535     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-016-7596-3     Document Type: Review

References (76)

1. Ahlgren HG, Benedetti A, Landry JS, Bernier J, Matouk E, Radzioch D, Lands LC, Rousseau S, Nguyen D (2015) Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients. BMC Pulm Med 15:67
2. Baldan R, Cigana C, Testa F, Bianconi I, De Simone M, Pellin D, Di Serio C, Bragonzi A, Cirillo DM (2014) Adaptation of Pseudomonas aeruginosa in cystic fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection. PLoS One 9:e89614
3. Barnabie PM, Whiteley M (2015) Iron-mediated control of Pseudomonas aeruginosa-Staphylococcus aureus interactions in the cystic fibrosis lung. J Bacteriol 197:2250–2251
4. Biswas L, Biswas R, Schlag M, Bertram R, Gotz F (2009) Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl Environ Microbiol 75:6910–6912
5. Bouvier NM (2016) Cystic fibrosis and the war for iron at the host-pathogen battlefront. Proc Natl Acad Sci 113:1480–1482. doi:10.1073/pnas.1525101113
6. Bryan LE, Van Den Elzen HM (1977) Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother 12:163–177
7. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH (1999) Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 43:1379–1382
8. Cassat JE, Skaar EP (2013) Iron in infection and immunity. Cell Host Microbe 13:509–519
9. Chambers HF, Deleo FR (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7:629–641
10. Costerton JW (2001) Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 9:50–52
11. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM (1995) Microbial biofilms. Annu Rev Microbiol 49:711–745
12. Dalton T, Dowd SE, Wolcott RD, Sun Y, Watters C, Griswold JA, Rumbaugh KP (2011) An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS One 6:e27317
13. DeLeon S, Clinton A, Fowler H, Everett J, Horswill AR, Rumbaugh KP (2014) Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model. Infect Immun 82:4718–4728
14. Deziel E, Lepine F, Milot S, He J, Mindrinos MN, Tompkins RG, Rahme LG (2004) Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A 101:1339–1344
15. Diggle SP, Matthijs S, Wright VJ, Fletcher MP, Chhabra SR, Lamont IL, Kong X, Hider RC, Cornelis P, Camara M, Williams P (2007) The Pseudomonas aeruginosa 4-quinolone signal molecules HHQ and PQS play multifunctional roles in quorum sensing and iron entrapment. Chem Biol 14:87–96
16. Filkins LM, O’Toole GA (2015) Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat. PLoS Pathog 11:e1005258
17. Filkins LM, Graber JA, Olson DG, Dolben EL, Lynd LR, Bhuju S, O’Toole GA (2015) Co-culture of Staphylococcus aureus with Pseudomonas aeruginosa drives S. aureus towards fermentative metabolism and reduced viability in a cystic fibrosis model. J Bacteriol 197:2252–2264. doi:10.1128/JB.00059-15
18. Foundation, Cystic Fibrosis (2014) Patient registry annual data report 2014. Cystic Fibrosis Foundation, Bethesda
19. Fugere A, Lalonde Seguin D, Mitchell G, Deziel E, Dekimpe V, Cantin AM, Frost E, Malouin F (2014) Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients. PLoS One 9:e86705
20. Gallagher LA, McKnight SL, Kuznetsova MS, Pesci EC, Manoil C (2002) Functions required for extracellular quinolone signaling by Pseudomonas aeruginosa. J Bacteriol 184:6472–6480
21. Gotz F, Mayer S (2013) Both terminal oxidases contribute to fitness and virulence during organ-specific Staphylococcus aureus colonization. Mbio 4:e00976-13
22. Hammer ND, Skaar EP (2011) Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu Rev Microbiol 65:129–147
23. Hammer ND, Reniere ML, Cassat JE, Zhang Y, Hirsch AO, Indriati Hood M, Skaar EP (2013) Two heme-dependent terminal oxidases power Staphylococcus aureus organ-specific colonization of the vertebrate host. Mbio 4:e00241-13
24. Heeb S, Fletcher MP, Chhabra SR, Diggle SP, Williams P, Camara M (2011) Quinolones: from antibiotics to autoinducers. FEMS Microbiol Rev 35:247–274
25. Hoffman LR, Deziel E, D’Argenio DA, Lepine F, Emerson J, McNamara S, Gibson RL, Ramsey BW, Miller SI (2006) Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 103:19890–19895
26. Hubert D, Reglier-Poupet H, Sermet-Gaudelus I, Ferroni A, Le Bourgeois M, Burgel PR, Serreau R, Dusser D, Poyart C, Coste J (2013) Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis. J Cyst Fibros 12:497–503
27. Hunter RC, Asfour F, Dingemans J, Osuna BL, Samad T, Malfroot A, Cornelis P, Newman DK (2013) Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. Mbio 4:e00557-13
28. Huse HK, Kwon T, Zlosnik JEA, Speert DP, Marcotte EM, Whiteley M (2010) Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. Mbio 1:e00199-10
29. Konings AF, Martin LW, Sharples KJ, Roddam LF, Latham R, Reid DW, Lamont IL (2013) Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun 81:2697–2704
30. Korgaonkar AK, Whiteley M (2011) Pseudomonas aeruginosa enhances production of an antimicrobial in response to N-acetylglucosamine and peptidoglycan. J Bacteriol 193:909–917
31. Korgaonkar A, Trivedi U, Rumbaugh KP, Whiteley M (2013) Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection. Proc Natl Acad Sci U S A 110:1059–1064
32. Lechner S, Lewis K, Bertram R (2012) Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol 22:235–244
33. Lightbown JW, Jackson FL (1956) Inhibition of cytochrome systems of heart muscle and certain bacteria by the antagonists of dihydrostreptomycin: 2-alkyl-4-hydroxyquinoline N-oxides. Biochem J 63:130–137
34. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC (2001) Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 153:345–352
35. Lipuma JJ (2010) The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 23:299–323
36. Lister PD, Wolter DJ, Hanson ND (2009) Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22:582–610
37. Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265–1273
38. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194–222
39. Lynch SV, Bruce KD (2013) The cystic fibrosis airway microbiome. Cold Spring Harb Perspect Med 3:a009738
40. Machan ZA, Taylor GW, Pitt TL, Cole PJ, Wilson R (1992) 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother 30:615–623
41. Maresso AW, Schneewind O (2006) Iron acquisition and transport in Staphylococcus aureus. Biometals 19:193–203
42. Marsland BJ, Gollwitzer ES (2014) Host-microorganism interactions in lung diseases. Nat Rev Immunol 14:827–835
43. Martin LW, Reid DW, Sharples KJ, Lamont IL (2011) Pseudomonas siderophores in the sputum of patients with cystic fibrosis. Biometals 24:1059–1067
44. Mashburn LM, Jett AM, Akins DR, Whiteley M (2005) Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture. J Bacteriol 187:554–566
45. Meyer JM (2000) Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species. Arch Microbiol 174:135–142
46. Meyer JM, Stintzi A, De Vos D, Cornelis P, Tappe R, Taraz K, Budzikiewicz H (1997) Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems. Microbiology 143(Pt 1):35–43
47. Michelsen CF, Christensen AM, Bojer MS, Hoiby N, Ingmer H, Jelsbak L (2014) Staphylococcus aureus alters growth activity, autolysis, and antibiotic tolerance in a human host-adapted Pseudomonas aeruginosa lineage. J Bacteriol 196:3903–3911
48. Monod J (1949) The growth of bacterial cultures. Annu Rev Microbiol 3:371–394
49. Murray JL, Connell JL, Stacy A, Turner KH, Whiteley M (2014) Mechanisms of synergy in polymicrobial infections. J Microbiol 52:188–199
50. Nairz M, Schroll A, Sonnweber T, Weiss G (2010) The struggle for iron—a metal at the host-pathogen interface. Cell Microbiol 12:1691–1702
51. Nguyen AT, Jones JW, Ruge MA, Kane MA, Oglesby-Sherrouse AG (2015) Iron depletion enhances production of antimicrobials by Pseudomonas aeruginosa. J Bacteriol 197:2265–2275. doi:10.1128/JB.00072-15
52. Nguyen AT, O’Neill MJ, Watts AM, Robson CL, Lamont IL, Wilks A, Oglesby-Sherrouse AG (2014) Adaptation of iron homeostasis pathways by a Pseudomonas aeruginosa pyoverdine mutant in the cystic fibrosis lung. J Bacteriol 196:2265–2276. doi:10.1128/JB.01491-14
53. Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48:1429–1449
54. Ochsner UA, Johnson Z, Vasil ML (2000) Genetics and regulation of two distinct haem-uptake systems, phu and has, in Pseudomonas aeruginosa. Microbiology 146(Pt 1):185–198
55. Ochsner UA, Vasil AI, Vasil ML (1995) Role of the ferric uptake regulator of Pseudomonas aeruginosa in the regulation of siderophores and exotoxin A expression: purification and activity on iron-regulated promoters. J Bacteriol 177:7194–7201
56. Otto BR, Verweij-van Vught AM, MacLaren DM (1992) Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit Rev Microbiol 18:217–233
57. Pan XS, Hamlyn PJ, Talens-Visconti R, Alovero FL, Manzo RH, Fisher LM (2002) Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones. Antimicrob Agents Chemother 46:2498–2506
58. Pernet E, Guillemot L, Burgel PR, Martin C, Lambeau G, Sermet-Gaudelus I, Sands D, Leduc D, Morand PC, Jeammet L, Chignard M, Wu Y, Touqui L (2014) Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity. Nat Commun 5:5105
59. Pesci EC, Milbank JB, Pearson JP, McKnight S, Kende AS, Greenberg EP, Iglewski BH (1999) Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 96:11229–11234
60. Peters BM, Jabra-Rizk MA, O’May GA, Costerton JW, Shirtliff ME (2012) Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev 25:193–213
61. Price KE, Hampton TH, Gifford AH, Dolben EL, Hogan DA, Morrison HG, Sogin ML, O’Toole GA (2013) Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 1:27
62. Proctor RA, Kriegeskorte A, Kahl BC, Becker K, Loffler B, Peters G (2014) Staphylococcus aureus small colony variants (SCVs): a road map for the metabolic pathways involved in persistent infections. Front Cell Infect Microbiol 4:99
63. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, Peters G (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4:295–305
64. Quinn RA, Lim YW, Maughan H, Conrad D, Rohwer F, Whiteson KL (2014) Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung. Mbio 5:e00956-13
65. Rogan MP, Taggart CC, Greene CM, Murphy PG, O’Neill SJ, McElvaney NG (2004) Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis 190:1245–1253
66. Rogers GB, Hoffman LR, Whiteley M, Daniels TW, Carroll MP, Bruce KD (2010) Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends Microbiol 18:357–364
67. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, Surette MG (2008) Discerning the complexity of community interactions using a drosophila model of polymicrobial infections. PLoS Pathog 4:e1000184
68. Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O (2004) Iron-source preference of Staphylococcus aureus infections. Science 305:1626–1628
69. Stacy A, McNally L, Darch SE, Brown SP, Whiteley M (2016) The biogeography of polymicrobial infection. Nat Rev Microbiol 14:93–105
70. Ster C, Beaudoin F, Diarra MS, Jacques M, Malouin F, Lacasse P (2010) Evaluation of some Staphylococcus aureus iron-regulated proteins as vaccine targets. Vet Immunol Immunopathol 136:311–318
71. Surette MG (2013) The cystic fibrosis lung microbiome. Am Thorac Soc 11:61–65
72. Takase H, Nitanai H, Hoshino K, Otani T (2000) Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice. Infect Immun 68:1834–1839
73. Voggu L, Schlag S, Biswas R, Rosenstein R, Rausch C, Gotz F (2006) Microevolution of cytochrome bd oxidase in staphylococci and its implication in resistance to respiratory toxins released by Pseudomonas. J Bacteriol 188:8079–8086
74. Wang Y, Wilks JC, Danhorn T, Ramos I, Croal L, Newman DK (2011) Phenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition. J Bacteriol 193:3606–3617
75. Wood TK, Knabel SJ, Kwan BW (2013) Bacterial persister cell formation and dormancy. Appl Environ Microbiol 79:7116–7121
76. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, Rau MH, Hansen SK, Folkesson A, Johansen HK, Ciofu O, Hoiby N, Sommer MO, Molin S (2011) Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci U S A 108:7481–7486